FDA warns clarithromycin could cause death in patients with heart disease
www.pulmccm.org
The U.S. FDA is warning physicians against prescribing the antibiotic clarithromycin to patients with coronary artery disease. In long-term follow up of a randomized controlled trial, there was an unexpectedly higher rate of death in patients who received a two-week treatment course of clarithromycin, compared to placebo.
FDA warns clarithromycin could cause death in patients with heart disease
FDA warns clarithromycin could cause death in…
FDA warns clarithromycin could cause death in patients with heart disease
The U.S. FDA is warning physicians against prescribing the antibiotic clarithromycin to patients with coronary artery disease. In long-term follow up of a randomized controlled trial, there was an unexpectedly higher rate of death in patients who received a two-week treatment course of clarithromycin, compared to placebo.
Comments on this post are for paid subscribers